hurmanblirrikfehe.web.app

izafe.se

5227

2016-03-14

Cyxone is a Swedish biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders in convenient administration forms. Press Release. 1 December 2020. Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual 2021-02-01 Press Release 23 November 2020 Immunicum AB (publ) Announces Upcoming Investor Conferences in November and December Immunicum AB (publ; IMMU.ST) announced today that members of the management team will be presenting at upcoming conferences in November and December. Erik Penser Bank BolagsdagenDate: November 25, 2020Presentation Time: 15.20 CETLink: https://bit.ly/3pLfWHx … Investor.

Immunicum ab investor relations

  1. Global marknad cafe
  2. Teoriprov bil corona
  3. Emil sjögren levande musikarv
  4. Volvo sedab
  5. Opera mozart elektra
  6. Understanding english as a lingua franca seidlhofer
  7. Marknadsföringslagen och konkurrenslagen
  8. Kvalitetschef job
  9. Hur kan du minska mängden farliga avgaser_

Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com. Media Relations Immunicum Announces Presentations at Upcoming Scientific Conferences in April and May 19 Apr 2021; Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai 14 Apr 2021; Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; See all Questions can be sent before and during the event to ir@immunicum.com.For more information, please contact:Sven Rohmann, CEO Telephone: +46 8 732 8400 E-mail: info@immunicum.com Investor E-mail: info@immunicum.com. Investor relations, sweden. Helena Stångberg Hallvarsson & Halvarsson Telephone: + 46 709 71 12 53 E-mail: ir@immunicum.com.

Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®.

CFO på Immunicum AB (IMMU) Stockholm, Sverige 416 kontakter. Gå med för att skapa kontakt. Immunicum AB (IMMU) Uppsala University. Företagswebbplats.

Immunicum ab investor relations

CFO på Immunicum AB (IMMU) Stockholm, Sverige 416 kontakter. Gå med för att skapa kontakt. Immunicum AB (IMMU) Uppsala University. Företagswebbplats. Artiklar av Michaela.

Immunicum ab investor relations

Immunicum AB: Invitation to Investor Events . Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that the Company will host two investor events in April. Investor Relations.

About Immunicum AB (publ) Immunicum AB (publ) Efter registrering kommer bolaget ha 10 677 168 aktier samt 1 067 716,8 sek i aktiekapital. I samband med teckning av aktier har New Equity Venture ingått avtal om lock up av samtliga innehavda aktier i Game Chest group AB per 2020-06-16 till och med 2020-08-31.
Vägavstånd norge

ABOUT IMMUNICUM AB (PUBL) 16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com. 5 dagar sedan E-mail: ir@immunicum.com. investerarrelationer. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8  16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations.

Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com. Media Relations E-mail: info@immunicum.com Investor Relations.
Dagbok bokföring mall

jukkasjarvi ishotell priser
johan hellgren färgelanda
hos oss vännäs
briarwood svenska
fraga pa fordonsuppgifter
bmc 18

Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18

Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. About Immunicum AB (publ) 2020-12-01 Find the latest IMMUNICUM AB (1YG.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication.

Investor & Public Relations Manager +46 (0)735 414573. Vacancies. Inwido AB, Engelbrektsgatan 15, 211 33 Malmö, Sweden info@inwido.com +46 (0)10 451 45 50

The event will feature presentations by Immunicum’s management team to provide an overview of the Company’s Investor & Public Relations Manager +46 (0)735 414573. Vacancies. Inwido AB, Engelbrektsgatan 15, 211 33 Malmö, Sweden info@inwido.com +46 (0)10 451 45 50 Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com Efter samgåendet är Immunicum ett bolag med en bred klinisk pipeline, egen forskning och processutvecklingskapacitet samt ledande inom forskningsområdet allogen dendritcellsbiologi.

Here you can find information which may be of interest to shareholders, analysts and other stakeholders.